Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: March 2017
CMBG Receives US$2.29 Million Grant For Stem Cell Therapy – Asian Scientist Magazine
Posted: March 9, 2017 at 6:43 am
Chinas Cellular Biomedicine Group has received US$2.29 million to support pre-clinical studies of stem cell therapy for knee osteoarthritis.
Asian Scientist Newsroom | March 9, 2017 | Pharma
AsianScientist (Mar. 9, 2017) - Cellular Biomedicine Group Inc., a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases, has been awarded US$2.29 million by the governing Board of the California Institute for Regenerative Medicine (CIRM) to support pre-clinical studies of AlloJoin, CBMGs Off-the-Shelf allogeneic human adipose-derived mesenchymal stem cells for the treatment of knee osteoarthritis in the United States.
While CBMG recently commenced two Phase I human clinical trials in China using CAR-T to treat relapsed/refractory CD19+ B-cell acute lymphoblastic leukemia (ALL) and refractory diffuse large B-cell lymphoma (DLBCL) as well as an ongoing Phase I trial in China for AlloJoin in knee osteoarthritis, this latest announcement represents CBMGs initial entrance into the United States for its off-the-shelf allogeneic stem cell candidate AlloJoin.
The US$2.29 million was granted under the CIRM 2.0 program, a comprehensive collaborative initiative designed to accelerate the development of stem cell-based treatments for people with unmet medical needs. After the award, CIRM will be a more active partner with its recipients to further increase the likelihood of clinical success and help advance a pre-clinical applicants research along a funding pipeline towards clinical trials.
CBMGs knee osteoarthritis pre-clinical program is considered late-stage, and therefore it meets CIRM 2.0s intent to accelerate support for clinical stage development for identified candidates of stem cell treatments that demonstrate scientific excellence.
We are deeply appreciative to CIRM for their support and validation of the therapeutic potential of our knee osteoarthritis therapy, said Mr. Tony (Bizuo) Liu, Chief Executive Officer of CBMG. The CIRM grant is the first step in bringing our allogeneic human adipose-derived mesenchymal stem cell treatment for knee osteoarthritis (AlloJoin) to the U.S. market.
In order to demonstrate comparability with cell banks previously produced in China for our U.S. IND filing, we are addressing the pre-clinical answers required for the FDA. With the funds provided by CIRM, we will replicate and validate the manufacturing process and control system at the cGMP facility located at Childrens Hospital Los Angeles to support the filing of an IND with the FDA.
CBMG recently announced promising interim three-month safety data from its Phase I clinical trial in China for AlloJoin, its off-the-shelf allogeneic stem cell therapy for knee osteoarthritis. The trial is on schedule to be completed by the third quarter of 2017.
Source: Cellular Biomedicine Group Inc; Photo: Shutterstock. Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
Read this article:
CMBG Receives US$2.29 Million Grant For Stem Cell Therapy - Asian Scientist Magazine
Posted in Cell Therapy
Comments Off on CMBG Receives US$2.29 Million Grant For Stem Cell Therapy – Asian Scientist Magazine
Can sweat patches revolutionise diabetes? – BBC News
Posted: March 9, 2017 at 6:42 am
Can sweat patches revolutionise diabetes? BBC News And in extra tests on mice, the sensor was hooked up to a patch of tiny needles to automatically inject diabetes medication. The team at the Seoul National University were trying to overcome the need for "painful blood collection" needed in diabetes ... |
Continue reading here:
Can sweat patches revolutionise diabetes? - BBC News
Posted in Diabetes
Comments Off on Can sweat patches revolutionise diabetes? – BBC News
MannKind Corp. to sponsor TV series on tackling diabetes – Santa Clarita Valley Signal
Posted: March 9, 2017 at 6:42 am
MannKind Corp. will sponsor a new television series this summer on the effects of poorly managed diabetes and its impact on people with the disease.
Reversed will air on Discovery Life Channel. It was created and will be hosted by Charles Mattocks, a celebrity chef and diabetes advocate.
MannKind is continually seeking platforms to increase awareness around the challenges, opportunities and success people living with diabetes encounter on a daily basis, said Michael Castagna, the companys chief commercial officer, in a statement.
The show will follow the lives of individuals affected by diabetes and their struggle to change their diet, exercise and mindset about the disease. It will feature experts such as diabetes educators, endocrinologists, therapists, nutritionists, and trainers, as well as celebrity guests who are also living with diabetes, to help encourage the contestants.
Mattocks, a nephew of Bob Marley, said, My uncle made an impact on the world through music and my vision is to impact health. Reversed is about changing the behavior of those with diabetes.
MannKind, the Valencia-based maker of Afrezza, an inhalable form of insulin, is working with Mattocks production company, Bella & Elle Media LLC.
Read more from the original source:
MannKind Corp. to sponsor TV series on tackling diabetes - Santa Clarita Valley Signal
Posted in Diabetes
Comments Off on MannKind Corp. to sponsor TV series on tackling diabetes – Santa Clarita Valley Signal
Merck aims to put Amazon’s Alexa to work on voice-enabled diabetes tools – FiercePharma
Posted: March 9, 2017 at 6:42 am
Alexa? Help pharma find patient solutions.
Thats what Merck & Co. is aiming for in its new partnership with Amazon Web Services to developdigital voice-enabled solutions for people living with chronic diseases.
Using Amazon Lex, the brains behind the Amazon Echo device and its well-known voice-enabled assistant Alexa, Merck plans to initially work on diabetes. Its first initiative will be a call to entrepreneurs, techies and industry types foran innovation challenge expected to begin within the next month.
The yet-to-be-named challenge will be run by strategy and innovation consultancyLuminary Labs. While specifics havent been released, the call to action will be open to solutions broadly enough that innovators of all stripes can come up with really novel ideas but being narrow enough to provide guidance and carefully evaluate submissions, said Sara Holoubek, founder and CEO of Luminary Labs.
An independent jury will evaluate the submissions based on their use ofvoice-enabled technology thataddresses Type 2 diabetes patient issues.
Merck's long-term planis to create tools for otherchronic diseases using the same Amazon Lex platform and the voice-enabled Alexa home system.
Analysts estimate Amazon will sell more than 110 million Amazon Echo devices over the next four years, and many are already pointing to healthcare as an important item on Alexa'seventual to-do list.
Users will soon go far beyond turning on lights or calling an Uber, and will venture deeper into healthcare, helping people better manage treatments and communicate with caregivers," Luminary noteson its website. "From reminding people of their nutrition plans to scheduling their insulin dosages, the Merck-sponsored Alexa challenge will call on developers to push the boundaries of voice technology for people with diabetes."
See more here:
Merck aims to put Amazon's Alexa to work on voice-enabled diabetes tools - FiercePharma
Posted in Diabetes
Comments Off on Merck aims to put Amazon’s Alexa to work on voice-enabled diabetes tools – FiercePharma
Health Check: Research into diabetes complication – Turn to 10
Posted: March 9, 2017 at 6:42 am
by BARBARA MORSE SILVA, NBC 10 NEWS
New biomedical research shows promise in fighting a complication of diabetes.
Richard Clements, Ph.D., is an assistant professor at Brown University and one of the researchers on this project, which was recently funded by the Brown University-based Advance Clinical and Translational Research initiative.
The lab-based, very preliminary research is looking at the vascular system in diabetics and why the blood vessels dont always dilate to accommodate increased blood flow. Thats important for several reasons.
"That can lead to a whole host of problems, said Clements. Vascular problems, coronary artery disease, peripheral vascular disease as well as higher blood pressure."
As part of this research, discarded tissue from diabetic and non-diabetic patients is being used.
"That we can then take and mount in this set up and then we can give it all sorts of drugs without having to worry about patient safety because it's not in the patient anymore," explained Clements.
And then they can, in this lab, measure which drugs improve the condition. Right now, this research is only in the lab. But, eventually, it will involve animal and then human testing.
"This is kind of the beginning stages of what could, 10 years down the line, turn into some sort of treatment," said Clements.
This is one of the first pilot awards from the Brown University-based Advance Clinical Translational Research initiative, which received funding from the National Institute of General Medical Sciences.
The total of this five-year program award is $19.5 million. Its purpose is to fund collaborative research involving multiple partners, depending on the project, including researchers from Brown University, Lifespan, Care New England, the Providence VA Medical Center, URI and the Rhode Island Quality Institute.
Originally posted here:
Health Check: Research into diabetes complication - Turn to 10
Posted in Diabetes
Comments Off on Health Check: Research into diabetes complication – Turn to 10
Poor Diet Tied to Heart Disease, Diabetes Deaths – WebMD
Posted: March 9, 2017 at 6:42 am
By Karen Pallarito
HealthDay Reporter
TUESDAY, March 7, 2017 (HealthDay News) -- Nearly half of all deaths from heart disease, stroke and diabetes in the United States are associated with diets that skimp on certain foods and nutrients, such as vegetables, and exceed optimal levels of others, like salt, a new study finds.
Using available studies and clinical trials, researchers identified 10 dietary factors with the strongest evidence of a protective or harmful association with death due to "cardiometabolic" disease.
"It wasn't just too much 'bad' in the American diet; it's also not enough 'good,'" said lead author Renata Micha.
"Americans are not eating enough fruits, vegetables, nuts/seeds, whole grains, vegetable oils or fish," she said.
Micha is an assistant research professor at the Tufts University School of Nutrition Science and Policy in Boston.
The researchers used data from multiple national sources to examine deaths from cardiometabolic diseases -- heart disease, stroke and type 2 diabetes -- in 2012, and the role that diet may have played.
"In the U.S. in 2012, we observed about 700,000 deaths due to those diseases," Micha said. "Nearly half of these were associated with suboptimal intakes of the 10 dietary factors combined."
Too much salt in people's diets was the leading factor, accounting for nearly 10 percent of cardiometabolic deaths, according to the analysis.
The study identifies 2,000 milligrams a day, or less than 1 teaspoon of salt, as the optimal amount. While experts don't agree on how low to go, there is broad consensus that people consume too much salt, Micha noted.
Other key factors in cardiometabolic death included low intake of nuts and seeds, seafood omega-3 fats, vegetables, fruits and whole grains, and high intake of processed meats (such as cold cuts) and sugar-sweetened beverages.
Each of these factors accounted for between 6 percent and 9 percent of deaths from heart disease, stroke and diabetes.
"Optimal" intake of foods and nutrients was based on levels associated with lower disease risk in studies and clinical trials. Micha cautioned that these levels are not conclusive. Optimal intake "could be modestly lower or higher," she explained.
Low consumption of polyunsaturated fats (found in soybean, sunflower and corn oils) accounted for just over 2 percent of cardiometabolic deaths, according to the study. High consumption of unprocessed red meats (such as beef) was responsible for less than one half of 1 percent of these deaths, the analysis showed.
The take-home message: "Eat more of the good and less of the bad," Micha said.
Vegetable intake, for example, was considered optimal at four servings per day. That would be roughly equivalent to 2 cups of cooked or 4 cups of raw veggies, she said.
Fruit intake was deemed optimal at three daily servings: "For example, one apple, one orange and half of an average-size banana," she continued.
"And eat less salt, processed meats, and sugary-sweetened beverages," she said.
The study also found that poor diet was associated with a larger proportion of deaths at younger versus older ages, among people with lower versus higher levels of education, and among minorities versus whites.
Dr. Ashkan Afshin is acting assistant professor of global health at the University of Washington's Institute for Health Metrics and Evaluation.
"I commend the current study's authors for exploring sociodemographic factors, like ethnicity and education, and their role in the relationship of diet with cardiometabolic disease," said Afshin, who was not involved in the study.
"This is an area that deserves more attention so that we may fully understand the connection between diet and health," he said.
The study doesn't prove that improving your diet reduces risk of death from heart disease, stroke and diabetes, but suggests that dietary changes may have an impact.
"It is important to know which dietary habits affect health the most so that people can make healthy changes in how they eat and how they feed their families," Afshin said.
The study was published March 7 in the Journal of the American Medical Association.
In an accompanying journal editorial, researchers from Johns Hopkins University urged caution in interpreting the findings.
According to Noel Mueller and Dr. Lawrence Appel, the results may be biased by the number of dietary factors included, the interaction of dietary factors and the authors' "strong assumption" that evidence from observational studies implies a cause-and-effect relationship.
Still, the editorialists concluded that the likely benefits of an improved diet "are substantial and justify policies designed to improve diet quality."
WebMD News from HealthDay
SOURCES: Renata Micha, R.D., Ph.D., assistant research professor, Friedman School of Nutrition Science and Policy, Tufts University, Boston; Ashkan Afshin, M.D., Sc.D., acting assistant professor of global health, Institute for Health Metrics and Evaluation, University of Washington, Seattle; March 7, 2017, Journal of the American Medical Association
Continued here:
Poor Diet Tied to Heart Disease, Diabetes Deaths - WebMD
Posted in Diabetes
Comments Off on Poor Diet Tied to Heart Disease, Diabetes Deaths – WebMD
Northern California Stem Cell Treatment Center in Redding, CA
Posted: March 8, 2017 at 6:44 am
100+ Treatments In The Last Year Alone In Redding
This practice is dedicated to cutting edge, highly professional procurement and delivery of autologous mesenchymal stem cells. This field is exciting for us, as well as for our affiliated physicians, and being able to offer such innovative stem cell therapy is a privilege, though it comes with great responsibility.
The Northern California Stem Cell Treatment Center is partnered with a large global organization called Cell Surgical Network. This affiliation, involving over 50 centers worldwide, shares our passion for this work and allows our practice and our patients the ability to add consequentially to the scientific knowledge base in clinical stem cell treatments.
We are pleased to be able to utilize our over 90 years of combined experience and expertise in treating patients to help forge progress in this exciting type of medicine, and we are dedicated to safely delivering stem cell therapy to our patients. We've been treating patients in Redding for over a year and seen more than 100 cases come through our office.Though the advancements thus far have been phenomenal,we are on the cusp of even greater life-changing medical innovations.
Original post:
Northern California Stem Cell Treatment Center in Redding, CA
Posted in California Stem Cells
Comments Off on Northern California Stem Cell Treatment Center in Redding, CA
Area high schools to offer dual credit biotechnology courses through Ivy Tech – Greene County Daily World
Posted: March 8, 2017 at 6:42 am
Several area high schools will start offering students the opportunity to take dual credit courses through Ivy Tech and earn free college credit this spring.
Last fall, Ivy Tech Community College Bloomington was awarded a Perkins Competitive Grant from the Indiana Department of Education, worth $85,000, to increase rural career and technical education pathways in biotechnology, according to Cook Medical Content Specialist, Moriah Sowders.
The course will be available to students attending Brown County, Owen Valley, Eastern Greene and Bloomfield high schools.
Currently, the courses are taught by an Ivy Tech instructor, though the grant will also provide training for high school science teachers to begin teaching the course in the 2017-18 school year.
In an article previously published by the Greene County Daily World, Bloomfield Jr./Sr. High School announced it would begin piloting two courses, BIOT (biotechnology) 102, the survey of good manufacturing practices, in the fall semester beginning on Jan. 17, and BIOT 100, the survey of biotechnology in the spring semester.
Eastern Greene Principal Doug Lewis said a course began there in mid January and has been going well.
It helps prepare them for going into that field, they can get a leg up going into other classes or straight into the workforce, said Lewis.
Currently, Lewis said the course is taught by an instructor from Ivy Tech once a week, and the students also login online daily for course work. The course will be offered by an Eastern Greene teacher next semester, according to Lewis.
Cook Pharmica also provided an additional $15,000 to Ivy Tech Bloomington to help launch and sustain the program in the future by providing funding for textbooks which can then be reused by participating high schools.
We have a mission at Ivy Tech Bloomington to help fill the local industry skills gap, and one way we do that is through partnerships like this with Cook Pharmica, said Jennie Vaughan, chancellor at Ivy Tech Bloomington. With the help of this grant, high school students can take dual credit classes in biotechnology, developing a clear pathway toward employment in the life sciences, an industry thats thriving in our region.
Tedd Green, president of Cook Pharmica said, We appreciate the work Ivy Tech does to help students in the local community develop the skills they need to enter the workforce upon graduating high school. This program is a true community partnership that supports the education of our local youth and the workforce development needs of the growing life sciences industry in South Central Indiana. We are pleased to be a partner in this program.
According to Sowders, Cook Pharmica has grown to 715 employees and introduced its new My Cook Pathway education assistance program in 2016, which provides employees the opportunity to continue their education at no cost to them from day one when with the company.
To find out more information about Cook Pharmica visit http://www.cookpharmica.com or to find out more information about Ivy Tech Community College visit http://www.ivytech.edu
Follow this link:
Area high schools to offer dual credit biotechnology courses through Ivy Tech - Greene County Daily World
Posted in Biotechnology
Comments Off on Area high schools to offer dual credit biotechnology courses through Ivy Tech – Greene County Daily World
Scottish universities link to develop stem cell therapies – PharmaTimes – PharmaTimes
Posted: March 8, 2017 at 6:42 am
Researchers at the Universities of Dundee and Edinburgh in Scotland are looking to work with the pharmaceutical industry to improve understanding of the biological processes that could form the basis of new therapies to support tissue regeneration or repair.
The National Phenotypic Screening Centre (NPSC) at the University of Dundee and the Medical Research Council (MRC) Centre for Regenerative Medicine (CRM) at the University of Edinburgh have signed a Memorandum of Understanding to work more closely together on translating novel biological discoveries into new stem cell therapies that could address a wide range of conditions.
The UK Regenerative Medicine Platform-funded Engineering and exploiting the stem cell niche Hub, led by the CRM, is dedicated to increase understanding of the biology of stem cell niches and to exploiting this knowledge therapeutically to improve organ regeneration through endogenous repair and cell transplantation.
Finding new drugs which can activate endogenous regenerative pathways requires the development of cell-based assays able to reproduce the complex behaviour of the cells and tissues in patients; the NPSC specialises in developing such assays so they can be systematically screened using large libraries of drug-like molecules to uncover agents that can alter cell and tissue behaviour.
The alliance between the two centres will allow novel biological discoveries from CRM to benefit from the expertise and industrial drug screening infrastructure provided by the NPSC, which, it is hoped, will lead to new therapies.
Stem cell medicine is coming of age. This is a great opportunity for Scottish Universities to partner with industry to ensure we can translate excellent science to new therapies that can help patients with chronic disease, noted Professor Stuart Forbes, Director of the Centre for Regenerative Medicine and co-director of the Niche Hub.
Read the original:
Scottish universities link to develop stem cell therapies - PharmaTimes - PharmaTimes
Posted in Cell Medicine
Comments Off on Scottish universities link to develop stem cell therapies – PharmaTimes – PharmaTimes
Exercise prevents cellular aging by boosting mitochondria – Medical News Today
Posted: March 8, 2017 at 6:42 am
It is common knowledge that exercise imparts a smorgasbord of health benefits. What is not yet understood is how physical activity manages to reduce aging on a cellular level. New research into mitochondria lifts the lid on the processes involved.
Regular exercise has been shown to boost the immune system, heighten cognitive abilities, improve sleep, increase lifespan, and maintain muscle tone. Its benefits are proven; the research is conclusive.
However, the mechanisms that lie beneath exercise's positive effects remain in the shadows. How do physical activities translate into rebuilding organelles that degrade as we age? Which activities are best?
A new study, published this week in Cell Metabolism, takes a look under the hood and provides clues as to how these benefits might be produced.
The current study's senior author is Dr. Sreekumaran Nair, a diabetes researcher at the Mayo Clinic in Rochester, MN, and the research team was led by Matthew Robinson, who now works at the University of Oregon in Eugene.
In all, the study included 36 men and 36 women, split into two age groups: "young" (aged between 18 and 30) and "older" (aged between 65 and 80). These participants were further split into three exercise programs:
Taking a biopsy from the volunteer's thigh muscles, they compared the molecular makeup with a control group of sedentary volunteers. Lean muscle mass and insulin sensitivity were also assessed.
The team found that, although strength training was effective at building muscle mass, high-intensity interval training had the greatest effect at a cellular level, specifically on mitochondria.
Mitochondria are commonly referred to as the powerhouses of the cell; their primary function is to produce adenosine triphosphate - the molecule that transports chemical energy within cells. As we age, the capacity of mitochondria to generate energy slowly decreases.
By comparing proteomic and RNA-sequencing data across the exercise groups, the team found that exercise encourages cells to make more RNA copies of the genes that code for mitochondrial proteins and proteins responsible for muscle growth.
Younger volunteers carrying out interval training showed a 49 percent increase in mitochondrial capacity and, even more impressively, the older group saw a 69 percent increase.
High-intensity biking effectively reversed age-related decline in mitochondrial function.
Ribosomes, vital players in the synthesis of proteins, also received a boost from exercise - it increased their ability to build mitochondrial proteins, which explains the rise in both mitochondrial function and muscle hypertrophy.
Physical activity's ability to bolster protein production is important. Muscle cells, like brain and heart cells, do not divide frequently. This means that, as we age, function declines. As Dr. Nair explains: "Unlike liver, muscle is not readily regrown. The cells can accumulate a lot of damage." If exercise can restore or minimize the deterioration of ribosomes and mitochondria in muscle cells, there is a good chance that it does the same in other tissues.
In addition to the increase in mitochondrial capacity, the interval training also improved the participant's insulin sensitivity, lowering the risk of developing diabetes. However, this exercise type was less effective at improving muscle strength.
"Based on everything we know, there's no substitute for these exercise programs when it comes to delaying the aging process. These things we are seeing cannot be done by any medicine."
Dr. Sreekumaran Nair
Although this study was not focused on making recommendations about duration or exercise type, Dr. Nair says: "If people have to pick one exercise, I would recommend high-intensity interval training, but I think it would be more beneficial if they could do 3-4 days of interval training and then a couple of days of strength training."
The study clearly demonstrates how exercise can increase the output of specific organelles. This relationship is likely to play a key part in slowing cellular aging.
Dr. Nair and his team plan to extend their deep dive into the cellular benefits of exercise in other tissue types. In the future, these findings could potentially be used to target specific pathways and reduce the impact of aging. In time, perhaps these positive changes could be triggered artificially, but as Dr. Nair says: "There are substantial basic science data to support the idea that exercise is critically important to prevent or delay aging. There's no substitute for that."
Learn how just 20 minutes of exercise can reduce inflammation.
See the article here:
Exercise prevents cellular aging by boosting mitochondria - Medical News Today
Posted in Cell Medicine
Comments Off on Exercise prevents cellular aging by boosting mitochondria – Medical News Today
